Browsing by Subject "biosimilar exchange"
Now showing items 1-1 of 1
-
Long-term safety and efficacy of biosimilar infliximab among patients with inflammatory arthritis switched from reference product
(Dove Medical Press Ltd., 2017-03-01)Purpose: To evaluate the efficacy and safety of the biosimilar infliximab in adult patients with inflammatory arthritis switched from reference product in our center. Patients and methods: In April 2014, patients attending ...